SGK1 and breast carcinoma: In this study using PC12 cells, GO- and KEGG-term analysis of SGK1 inhibition-induced DEGs were also enriched for cell migration, cell junctions, cytoskeletal protein association, development of multicellular organisms, breast cancer, hepatocellular carcinoma, and IL-17 and TNF signaling pathways; however, the association of these processes with SGK1 in neuronal cells is unclear.